New, Molecular Cervical Cancer Screening Technologies: Results From PATH's START-UP Project
This brief describes two human papillomavirus (HPV) screening methods developed and tested by PATH for low-resource settings: the careHPV™ DNA test and the OncoE6™ cervical test.
Publication date: April 2013
New, Molecular Cervical Cancer Screening Technologies
- PDFHard copies are not available.